MktsMarkets

Kiora Pharmaceuticals, Inc.
NASDAQ: KPRXKey statistics
KPRX News
Stories mentioning KPRX from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 20.00 | |
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | |||||||
| Operating Expenses | ||||||||
| Research & Development | 2,124 | 2,928 | 2,730 | 2,590 | 2,532 | 1,924 | 2,185 | 2,049 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 2,510 | 7,311 | 794.00 | 2,396 | 2,330 | 2,565 | 3,602 | 2,565 |
| Operating Income (Loss) | (2,510) | (7,311) | (794.00) | (2,396) | (2,330) | (2,565) | (3,602) | (2,545) |
| Interest Income | 225.00 | 277.00 | 342.00 | |||||
| Interest Expense | ||||||||
| Other Expense | (47.00) | (26.00) | (24.00) | (94.00) | (16.00) | 97.00 | (60.00) | (19.00) |
| Pretax Income | (2,418) | (7,166) | (616.00) | (2,265) | (2,070) | (2,158) | (3,413) | (2,222) |
| Tax Provision | 0.00 | (650.00) | (643.00) | (112.00) | 123.00 | 2,065 | 0.00 | 0.00 |
| Net Income (Loss) | (2,418) | (6,517) | 27.00 | (2,152) | (2,193) | (4,223) | (3,413) | (2,222) |
| Earnings Per Share (Basic) | (0.58) | (1.56) | 0.01 | (0.54) | (0.52) | (1.09) | (0.81) | (0.53) |
| Earnings Per Share (Diluted) | (0.58) | (1.59) | 0.01 | (0.54) | (0.52) | (1.02) | (0.81) | (0.53) |
| Weighted Average Shares Outstanding (Basic) | 4,175 | 4,167 | 4,290 | 3,989 | 4,217 | 3,873 | 4,215 | 4,171 |
| Weighted Average Shares Outstanding (Diluted) | 4,175 | 4,104 | 4,362 | 3,989 | 4,217 | 4,125 | 4,215 | 4,171 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About KPRX
Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) is a stock listed on the Nasdaq Stock Market under the ticker symbol KPRX. It last traded at $1.23 (Nov 13, 2026, 4:00 PM ET), down 7.5% on the day. That gives Kiora Pharmaceuticals a market capitalisation of $5.4M.
Over the past 52 weeks KPRX has traded between $1.33 and $2.91.
For the quarter ended Mar 31, 2026 it reported a net loss of $2.4M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$2.4M |
| Dec 31, 2025 | $0 | -$6.5M |
| Sep 30, 2025 | $0 | $27.0K |
| Jun 30, 2025 | $0 | -$2.2M |
From Kiora Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…